Investor Ideas #Potcasts
621, #Cannabis News and #Stocks on the Move; (Nasdaq: $TLRY), (OTCQB: $HCANF), (CSE:
$DELC.C) (OTCQB: $DELCF). (CSE: $XBRA.C) (OTC: $XBRAF)
Delta, Kelowna, BC, January 13, 2022 (Investorideas.com
Newswire) www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/011322-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2022/cannabis-potcasts/01131TLRY-HCANF-DELC-DELCF-XBRA-XBRAF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Tilray,
Inc. (Nasdaq: TLRY) (TSX: TLRY), a leading global
cannabis-lifestyle and consumer packaged goods company inspiring and empowering
the worldwide community to live their very best life, reported their financial results for the
second fiscal quarter ended November 30, 2021 on Monday this week.
The Company also announced a new
parent name, Tilray Brands, Inc., reflecting the Company’s evolution from a
Canadian LP to a global consumer packaged goods company powerhouse with a
market leading portfolio of cannabis and lifestyle CPG brands.
Irwin D. Simon, Tilray’s Chairman
and Chief Executive Officer, stated, “Our second quarter performance reflects
notable success building high-quality and highly sought-after cannabis and
lifestyle CPG brands which, coupled with our scale, operational excellence and
broad global distribution, enabled us to increase sales and maintain
profitability despite sector-specific and macro-economic headwinds.”
Mr. Simon continued, “Looking at
performance highlights across key markets, we maintained our #1 cannabis market
share position in Canada – despite market saturation and related competitive
challenges -- on the strength of our brands and adept pricing and marketing
adjustments. Importantly, we believe these adjustments will enable us to
aggressively recapture share when the market right-sizes. In Germany – Europe’s
largest and most profitable medical cannabis market – our nearly 20% share
leads the market. We believe this, coupled with our infrastructure, will also
allow us to capture the adult-use market as legalization accelerates under the
new coalition government. Turning to the U.S., SweetWater Brewing and Manitoba
Harvest continued to invest in product innovation and acquisitions to enhance
awareness and distribution. These profitable businesses further provide an
opportunity to launch THC-based products upon federal legalization in the U.S.
Subsequent to the end of the fiscal quarter, we also expanded our spirits
portfolio through the acquisition of Breckenridge Distillery, deepening our
presence in the fast-growing spirits sector while also providing an immediate
contribution to earnings.”
Mr. Simon concluded, “The totality
of our performance, our prospects and our global platform make Tilray Brands'
opportunity as compelling as ever, driven by our success as a cannabis and
lifestyle CPG powerhouse and our relentless focus on delivering shareholder
value.”
Tilray’s stock rose 18% in Monday
morning trading, to $7.57, following the announcement.
According to a recent Barrows article this was “Thanks to last
year’s merging of the Aphria business with Tilray, sales grew about 20% in the
November quarter, to $155 million. But that is accounting for the business’s
continuing operations: the pro forma sales of the separate companies in the
year-earlier period were actually higher—at some $180 million. Tilray was
losing money badly back then. The November 2021 quarter showed a small profit,
even though free cash flow was negative.”
The article continued, “Simon’s team
is cleaning up the operations of the legacy Tilray business, and the November
2021 quarter saw balance-sheet adjustments for mispriced acquired inventories
and charges for product whose costs exceed Canadian sales prices. But synergies
from the Aphria combination will reap $80 million in annualized cost savings by
the end of the company’s May 2022 fiscal year, said financial chief Carl
Merton, and another $20 million in the following fiscal year.”
Delic
Holdings Corp (CSE: DELC) (OTCQB: DELCF), a leader in new medicines and
treatments for a modern world, announced that its subsidiary, Ketamine
Wellness Centers (KWC), has officially expanded operations into Utah with the
opening of its Salt Lake City location. KWC was acquired by Delic in September
2021 and currently operates 11 ketamine infusion treatment clinics across nine
states, delivering more than 61,000 treatments to date.
Located in the suburb of
Taylorsville at 6087 South Redwood Road, Suite B, KWC Salt Lake City is the
first of the company's clinics in Utah. With up to seven treatment rooms at the
facility, this location will be one of the largest ketamine clinics in the U.S.
and the largest ketamine infusion clinic in Utah. The clinic will also create 10
new jobs, with four filled at the outset and an additional six with a full
patient schedule.
"Utah currently experiences one
of the highest rates of mental health concerns in the country with lower access
to care, and KWC aims to serve this new community of patients struggling with
treatment-resistant conditions," said Kevin Nicholson, CEO of KWC and
Chief Operating Officer for Delic. "KWC is known for providing the highest
standard of care and we are committed to providing the most effective and
personalized treatment protocol to our patients and support and education to
their loved ones."
The launch of KWC Salt Lake City
allows Delic to execute its strategy of opening ketamine treatment centers in
growing cities with the goal of reaching the greatest number of patients and
providing reasonably priced treatments.
Matt Stang, co-founder and CEO of
Delic, explained, "As the pandemic enters its third year, the need for
effective, affordable options for mental health treatments is even more
critical. We are thrilled to be opening the first KWC clinic in Utah and
building on our promise to make these vital treatments more accessible by
expanding our network into underserved communities where they are most
needed."
To commemorate the grand opening,
KWC Salt Lake City will host several events for the community to learn more
about the clinic and ask questions about ketamine treatments, including an
in-person and virtual meet and greet and a spring event that will bring
together other local businesses.
Xebra
Brands Ltd. (CSE: XBRA) (OTC: XBRAF), a cannabis company, announced that it has commenced formal
cannabis cultivation in the Netherlands, including THC varietals.
As 1 of only 5 companies to be
selected by the Dutch government to participate in trial medicinal cannabis
cultivation, Xebra is endeavoring to be awarded 1 of 2 licenses, with a
contract for up to 6 years, providing for revenues of up to US$79 million
(€70.5 million), to co-supply all pharma-grade cannabis to be sold in the
Netherlands.
Cultivation in the Netherlands is
conducted in Xebra's indoor facility. Xebra's specific genetic varieties are
characterized by high production, compact flowers of excellent quality and fine
tasting terpene profiles, with a growth cycle of 12-16 weeks.
Xebra's Director of Operations in
the Netherlands, Harry von Duijne, is an experienced cannabis horticulture
expert with more than two decades of practicing horticulture. He had a leading role at Bedrocan NL® from 2014
and 2017, where he was responsible for managing every aspect of operations of a
state-of-the-art cannabis facility, from construction through cultivation and
processing, quality management, and GMP certification. Bedrocan® produces medicinal-grade cannabis
under contract for the Dutch Ministry of Health as the only licensed producer
in the Netherlands, and for many years was the only licenced producer in all of
Europe.
Halo
Collective Inc. (NEO: HALO) (OTCQB: HCANF) today announced that it is strategically
expanding into the functional beverage market with a proposed stock-based
acquisition of private company operating as H2C Beverages ("H2C") and
the entering into of a distribution and manufacturing agreement with Elegance
Brands Inc. Pursuant to the terms of the Distribution Agreement, Elegance has
agreed to purchase $30 million of Halo's H2C and Hushrooms™ branded products
during the 24-month period following the launch of the products (the
"Launch Period") and to distribute these products to retail outlets
in respective legal states across the United States.
Kiran Sidhu, Halo's Chief Executive
Officer, commented, "Nootropic nutraceuticals is a relatively new health
category that we believe is poised for robust growth. Our strategic acquisition
of H2C Beverages will bolster Halo's growth opportunities, even as the
recreational cannabis industry faces over-supply issues in our California and
Oregon markets. Elegance Brands is the perfect partner to manage and distribute
H2C and our functional mushroom brand Hushrooms to mainstream consumers."
Added Raj Beri, Elegance's CEO and
Founder, "Elegance has successfully established a distribution network
with a potential reach to tens of thousands of outlets nationwide that uniquely
positions for the significant growth expected in the beverages and functional
mushroom markets. We believe that Halo's innovative line of products will be
strong sellers alongside our portfolio of brands all built around innovation,
and we are excited to offer them to our expanding distribution customers."
Investor ideas reminds all listeners
to read our disclaimers and disclosures on the Investorideas.com website and
that this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
